Details for New Drug Application (NDA): 090872
✉ Email this page to a colleague
The generic ingredient in SUMATRIPTAN AND NAPROXEN SODIUM is naproxen sodium; sumatriptan succinate. There are forty-two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the naproxen sodium; sumatriptan succinate profile page.
Summary for 090872
Tradename: | SUMATRIPTAN AND NAPROXEN SODIUM |
Applicant: | Rising |
Ingredient: | naproxen sodium; sumatriptan succinate |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 500MG;EQ 85MG BASE | ||||
Approval Date: | Sep 4, 2018 | TE: | AB | RLD: | No |
Complete Access Available with Subscription